CoLucid Pharmaceuticals, Inc. (CLCD) has 26 open-market insider trades by 10 insiders since 2015. The most active filer is Linda C. Hogan.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| A/s Novo | 10% | — | 2 | $15.0M | 2016-09-09 |
| Life Science Ventures Vii L.p. Tvm | 10% | — | 1 | $5.0M | 2015-05-11 |
| Pappas Life Science Ventures Iii L.p. A.m. | 10% | — | 1 | $3.0M | 2015-05-11 |
| Brian H. Dovey | 10% Owner | — | 6 | $2.6M | 2016-08-03 |
| Linda C. Hogan | — | — | 7 | $2.2M | 2017-01-05 |
| Nicole Vitullo | 10% Owner | — | 1 | $2.1M | 2016-04-28 |
| A/s Novo | 10% Owner | — | 1 | $2.0M | 2016-09-09 |
| Thomas P. Mathers | CEO | — | 6 | $372K | 2017-03-01 |
| Matthew D. Dallas | CFO | — | 2 | $105K | 2017-03-01 |
| DP VI Associates, L.P. | 10% Owner | — | 1 | $2K | 2016-08-03 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Thomas P. Mathers | CEO | Sell | $52K | 2017-01-05 |
| Linda C. Hogan | — | Sell | $128K | 2017-01-03 |
| Matthew D. Dallas | CFO | Sell | $107K | 2017-01-03 |
| Bernice Kuca | Head & Clin. and Reg. Operations | Sell | $28K | 2017-01-03 |
| Linda C. Hogan | — | Sell | $65K | 2016-12-05 |
| Thomas P. Mathers | CEO | Sell | $116K | 2016-12-05 |
Companies that share insiders with CLCD, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Bernice Kuca | Head & Clin. and Reg. Operations | Sell | $27K | 2016-12-01 |
| Linda C. Hogan | — | Sell | $123K | 2016-12-01 |
| Matthew D. Dallas | CFO | Sell | $104K | 2016-12-01 |
| Thomas P. Mathers | CEO | Sell | $43K | 2016-11-07 |
| Linda C. Hogan | Head & Bus. Dev. and Strategy | Sell | $53K | 2016-11-04 |
| Linda C. Hogan | Head & Bus. Dev. and Strategy | Sell | $22K | 2016-11-01 |
| Linda C. Hogan | — | Sell | $62K | 2016-10-05 |
| Thomas P. Mathers | CEO | Sell | $111K | 2016-10-05 |
| Linda C. Hogan | — | Sell | $96K | 2016-10-03 |